Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.

Rodrigo Martino(Universitat Autònoma de Barcelona), A Domingo-Albós(Clínica Rementería), Salut Brunet(Institut Català d'Oncologia), Albert Altés(Hospital de Sant Pau), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), César Félix Sánchez Martínez, Josep Nomdedéu(Centre de Recherche Jean Pierre Aubert)
PubMed
March 1, 1994
Cited by 66

Related Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2015|740
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532